These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 576098)
1. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related]
2. Forces and direction of drug product selection legislation. Stewart JE Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281 [No Abstract] [Full Text] [Related]
3. The Ohio Generic Product Selection Law: influence on pharmacy practice. Hunter RH Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269 [No Abstract] [Full Text] [Related]
4. Guidelines for pharmacists performing product selection. Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394 [No Abstract] [Full Text] [Related]
5. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation. Segal R; Grines LL; Pathak DS Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459 [TBL] [Abstract][Full Text] [Related]
6. Attitudes of pharmacists and physicians toward Florida's drug product selection law. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871 [TBL] [Abstract][Full Text] [Related]
7. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists. Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108 [TBL] [Abstract][Full Text] [Related]
8. Drug product selection and the law. Fink JL Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846 [TBL] [Abstract][Full Text] [Related]
9. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978. Sumner ED; Karig AW; Hunt HH Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911 [TBL] [Abstract][Full Text] [Related]
10. FTC: our model product selection law relies on the pharmacist's expertise. Holmes PD Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271 [No Abstract] [Full Text] [Related]
11. Plan defeated, but pharmacists still seek ability to prescribe. Carrell S Am Med News; 1982 May; 25(18):3, 9. PubMed ID: 10324199 [No Abstract] [Full Text] [Related]
14. Understanding drug product selection legislation. Berger BA Contemp Pharm Pract; 1981; 4(2):89-93. PubMed ID: 10250914 [TBL] [Abstract][Full Text] [Related]
15. New York's generic drug substitution law. Kamen A N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574 [No Abstract] [Full Text] [Related]
16. Physician-ownership in pharmacies and drug repackagers. Hoffer GE Inquiry; 1975 Mar; 12(1):26-36. PubMed ID: 123219 [No Abstract] [Full Text] [Related]
17. Economic issues in the antisubstitution controversy. Sharpe TR Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879 [No Abstract] [Full Text] [Related]
18. Editorial: The pharmacist and drug product selection. Tice LF Am J Pharm Sci Support Public Health; 1974; 146(3):67-9. PubMed ID: 4851580 [No Abstract] [Full Text] [Related]
19. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle. Felch WC Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131 [No Abstract] [Full Text] [Related]
20. Brand substitution the consumer's viewpoint. Nelson AA; Gagnon JP J Am Pharm Assoc; 1975 Jul; 15(7):382-5, 91. PubMed ID: 1133442 [No Abstract] [Full Text] [Related] [Next] [New Search]